Genmab A/S (GNMSF) Operating margin 2023–2025
Genmab A/S (GNMSF) operating margin by fiscal year — reported operating income divided by reported revenue.
28.6%FY2025 · since FY2023: 32.3% → 28.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 28.6% | -2.5 pp |
| FY2024 | 31.1% | -1.2 pp |
| FY2023 | 32.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More GNMSF financial trends
GNMSF RevenueGNMSF Net incomeGNMSF Net marginGNMSF Gross profitGNMSF Gross marginGNMSF Operating incomeGNMSF Operating cash flowGNMSF Free cash flowGNMSF Capital expendituresGNMSF Return on equityGNMSF Stock buybacksGNMSF Dividends paidGNMSF Total assetsGNMSF Total liabilitiesGNMSF Shareholders’ equityGNMSF overview →